6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Back
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Journal article   Open access   Peer reviewed

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Robert J. Mentz, Jyotsna Garg, Frank W. Rockhold, Javed Butler, Carmine G. De Pasquale, Justin A. Ezekowitz, Gregory D. Lewis, Eileen O’Meara, Piotr Ponikowski, Richard W. Troughton, …
The New England journal of medicine, Vol.389(11), pp.975-986
14/09/2023
DOI: https://doi.org/10.1056/NEJMoa2304968
Handle:
https://hdl.handle.net/10523/16919

Abstract

Anemia Cardiology Cardiology General Heart Failure Hematology Oncology
In patients with heart failure with reduced ejection fraction and iron deficiency, ferric carboxymaltose therapy did not appear to differ from placebo in the composite of death, heart-failure hospitalizations, or walk distance.
url
https://doi.org/10.1056/NEJMoa2304968View
Published (Version of record)All Rights Reserved,  Open

Metrics

11 Record Views
126 Times Cited - Web of Science

Details

Logo image